I

Ilex Medical Ltd
TASE:ILX

Watchlist Manager
Ilex Medical Ltd
TASE:ILX
Watchlist
Price: 6 390 ILS -0.03% Market Closed
Market Cap: ₪714.1m

Net Margin

4.8%
Current
Declining
by 1.5%
vs 3-y average of 6.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.8%
=
Net Income
₪43.6m
/
Revenue
₪906.6m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
4.8%
=
Net Income
₪43.6m
/
Revenue
₪906.6m

Peer Comparison

Country Company Market Cap Net
Margin
IL
Ilex Medical Ltd
TASE:ILX
714.3m ILS
Loading...
US
Mckesson Corp
NYSE:MCK
102.5B USD
Loading...
US
Cencora Inc
NYSE:COR
68.8B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
67.7B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
50.3B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
35.3B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.1B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.6B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.4B HKD
Loading...

Market Distribution

In line with most companies in Israel
Percentile
61st
Based on 749 companies
61st percentile
4.8%
Low
-85 210% — -8.6%
Typical Range
-8.6% — 7.2%
High
7.2% — 23 652.1%
Distribution Statistics
Israel
Min -85 210%
30th Percentile -8.6%
Median 1.8%
70th Percentile 7.2%
Max 23 652.1%

Ilex Medical Ltd
Glance View

Market Cap
714.1m ILS
Industry
Health Care

Ilex Medical Ltd. engages in medical diagnostics field. The company is a supplier of in vitro diagnostic equipment and laboratory management software. The firm offers cutting-edge diagnostic equipment and reagent systems; nucleic acid testing (NAT) blood screening solutions; products for cancer screening, retro virus load, TB, and STDs, and other infectious diseases; laboratory information systems (LIS); and blood sugar monitoring products. Among the Company’s subsidiaries and affiliates are Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd and Medtechnica Ltd.

ILX Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
4.8%
=
Net Income
₪43.6m
/
Revenue
₪906.6m
What is Ilex Medical Ltd's current Net Margin?

The current Net Margin for Ilex Medical Ltd is 4.8%, which is below its 3-year median of 6.3%.

How has Net Margin changed over time?

Over the last 3 years, Ilex Medical Ltd’s Net Margin has decreased from 11.9% to 4.8%. During this period, it reached a low of 3.7% on Mar 31, 2025 and a high of 11.9% on Sep 30, 2022.

Back to Top